HomeVenture Capital

Venture Capital

Venture Capital

LinusBio Bucks Market Slowdown, Secures Additional $8M in A2 Funding with Increased Valuation

Life Sciences Times - 0
Venture Capital

LTZ Announces over $10 Million Pre-A+ Financing to Advance Development of its Immunotherapy Pipeline to Treat Cancer and Autoimmune Diseases

Life Sciences Times - 0
Venture Capital

Sekoia.io has Raised €35M in a New Round of Financing, a Record Amount for a European Cybersecurity Company in series A

Life Sciences Times - 0
Venture Capital

Syridex Bio Selected by NJEDA to Invest up to $5 Million in Early-Stage, New Jersey Life Science and Healthcare Companies

Life Sciences Times - 0
Venture Capital

AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million

Life Sciences Times - 0
Venture Capital

Axelera AI Raises $50M to Democratize Edge AI

Life Sciences Times - 0
Venture Capital

Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

Life Sciences Times - 0
Venture Capital

Nomi Health Acquires Arizona Clinic On Its Path to Help Solve the Opioid Crisis

Life Sciences Times - 0
Venture Capital

Myeloma Investment Fund Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma

Life Sciences Times - 0
Venture Capital

Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases

Life Sciences Times - 0
Venture Capital

Fifth Third Completes Acquisition of Big Data Healthcare, Further Accelerating Bank’s Digital Payments and Managed Services Offerings

Life Sciences Times - 0
Venture Capital

Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases

Life Sciences Times - 0
1...454647...115Page 46 of 115

Most Read